Literature DB >> 21395527

Electrochemistry in the mimicry of oxidative drug metabolism by cytochrome P450s.

Eslam Nouri-Nigjeh1, Rainer Bischoff, Andries P Bruins, Hjalmar P Permentier.   

Abstract

Prediction of oxidative drug metabolism at the early stages of drug discovery and development requires fast and accurate analytical techniques to mimic the in vivo oxidation reactions by cytochrome P450s (CYP). Direct electrochemical oxidation combined with mass spectrometry, although limited to the oxidation reactions initiated by charge transfer, has shown promise in the mimicry of certain CYP-mediated metabolic reactions. The electrochemical approach may further be utilized in an automated manner in microfluidics devices facilitating fast screening of oxidative drug metabolism. A wide range of in vivo oxidation reactions, particularly those initiated by hydrogen atom transfer, can be imitated through the electrochemically-assisted Fenton reaction. This reaction is based on O-O bond activation in hydrogen peroxide and oxidation by hydroxyl radicals, wherein electrochemistry is used for the reduction of molecular oxygen to hydrogen peroxide, as well as the reduction of Fe(3+) to Fe(2+). Metalloporphyrins, as surrogates for the prosthetic group in CYP, utilizing metallo-oxo reactive species, can also be used in combination with electrochemistry. Electrochemical reduction of metalloporphyrins in solution or immobilized on the electrode surface activates molecular oxygen in a manner analogous to the catalytical cycle of CYP and different metalloporphyrins can mimic selective oxidation reactions. Chemoselective, stereoselective, and regioselective oxidation reactions may be mimicked using electrodes that have been modified with immobilized enzymes, especially CYP itself. This review summarizes the recent attempts in utilizing electrochemistry as a versatile analytical and preparative technique in the mimicry of oxidative drug metabolism by CYP.
© 2011 Bentham Science Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21395527     DOI: 10.2174/138920011795202929

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  6 in total

1.  Cytochrome P450 is present in both ferrous and ferric forms in the resting state within intact Escherichia coli and hepatocytes.

Authors:  Wayne A Johnston; Dominic J B Hunter; Christopher J Noble; Graeme R Hanson; Jeanette E Stok; Martin A Hayes; James J De Voss; Elizabeth M J Gillam
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

Review 2.  N-Dealkylation of Amines.

Authors:  Ali Alipour Najmi; Rainer Bischoff; Hjalmar P Permentier
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

3.  On-line electrochemistry-bioaffinity screening with parallel HR-LC-MS for the generation and characterization of modified p38α kinase inhibitors.

Authors:  David Falck; Jon S B de Vlieger; Martin Giera; Maarten Honing; Hubertus Irth; Wilfried M A Niessen; Jeroen Kool
Journal:  Anal Bioanal Chem       Date:  2012-01-08       Impact factor: 4.142

4.  On-line electrochemical reduction of disulfide bonds: improved FTICR-CID and -ETD coverage of oxytocin and hepcidin.

Authors:  Simone Nicolardi; Martin Giera; Pieter Kooijman; Agnieszka Kraj; Jean-Pierre Chervet; André M Deelder; Yuri E M van der Burgt
Journal:  J Am Soc Mass Spectrom       Date:  2013-09-10       Impact factor: 3.109

Review 5.  Mass spectrometric methods for monitoring redox processes in electrochemical cells.

Authors:  Herbert Oberacher; Florian Pitterl; Robert Erb; Sabine Plattner
Journal:  Mass Spectrom Rev       Date:  2013-12-10       Impact factor: 10.946

6.  Nanoporous Gold Catalyst for the Oxidative N-Dealkylation of Drug Molecules: A Method for Synthesis of N-Dealkylated Metabolites.

Authors:  Ali Alipour Najmi; Elchin Jafariyeh-Yazdi; Mojgan Hadian; Jos Hermans; Rainer Bischoff; Jun Yue; Alexander Dömling; Arne Wittstock; Hjalmar P Permentier
Journal:  ChemMedChem       Date:  2022-04-05       Impact factor: 3.540

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.